<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dk.um.si/IzpisGradiva.php?id=88381"><dc:title>Henoch-Schönleinova purpura pri odraslem</dc:title><dc:creator>Skačej,	Helena	(Avtor)
	</dc:creator><dc:creator>Holc,	Iztok	(Avtor)
	</dc:creator><dc:creator>Pahor,	Artur	(Avtor)
	</dc:creator><dc:subject>sistemski vaskulitis</dc:subject><dc:subject>Henoch-Schönleinova purpura</dc:subject><dc:subject>odrasli bolnik</dc:subject><dc:description>Background: Henoch-Schonlein purpura (HSP) is a systemic inflammation of small-vessel walls that predominantly affects children. In adults, on the other hand, it appears rarely, and can be more severe. The disease is characterised by a tetrad of clinical signs which manifest the skin, joint, gastrointestinal, and kidney involvement. HSP is diagnosed using internationally-accepted criteria. At present, there is no effective specific therapy for children and adults. However, in cases of severe organ involvement, aggressive treatment may stabilise the disease. Case report: We present a case of a 59-year-old immunologically uncom- promised patient with an extremely severe form of HSP. Epidemiology, etiopathogenesis, clinical features, diagnostic procedures, differential diagnosis, treatment, and prognosis of the disease are discussed. Conclusions: The patient was treated with corticosteroids, human polyspecific immunoglobulins, and immunosuppressive agents. A satisfactory clinical remission has been achieved.</dc:description><dc:date>2009</dc:date><dc:date>2024-04-19 09:00:31</dc:date><dc:type>Znanstveno delo</dc:type><dc:identifier>88381</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
